News and Press Releases

Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi

May 22, 2026 – Globe Newswire

Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

April 8, 2026 – Globe Newswire

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

March 27, 2026 – Sanofi

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

January 6, 2026 – Globe Newswire

Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology

December 18, 2025 – Globe Newswire

Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System

October 27, 2025 – Incyte

Enable Injections Announces enFuse® System Regulatory Approval in Brazil and MRHA Medical Device Registration in the UK

August 12, 2025 – Globe Newswire